Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The type 1 diabetes gene TYK2 regulates β-cell development and its responses to interferon-α
Vikash Chandra, Hazem Ibrahim, Clémentine Halliez, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

The immunology of type 1 diabetes
Kevan C. Herold, Thomas Delong, Ana Luisa Perdigoto, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 6, pp. 435-451
Open Access | Times Cited: 47
Interferons are key cytokines acting on pancreatic islets in type 1 diabetes
Alexandra Coomans de Brachène, Maria Inês Alvelos, Florian Szymczak, et al.
Diabetologia (2024) Vol. 67, Iss. 5, pp. 908-927
Open Access | Times Cited: 23
Why does the immune system destroy pancreatic β-cells but not α-cells in type 1 diabetes?
Décio L. Eizirik, Florian Szymczak, Roberto Mallone
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 7, pp. 425-434
Closed Access | Times Cited: 32
Interferon-α promotes HLA-B-restricted presentation of conventional and alternative antigens in human pancreatic β-cells
Alexia Carré, Fatoumata Samassa, Zhicheng Zhou, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Inhibition of the type 1 diabetes candidate gene PTPN2 aggravates TNF-α-induced human beta cell dysfunction and death
Arturo Roca-Rivada, Sandra Marín-Cañas, Máikel L. Colli, et al.
Diabetologia (2023) Vol. 66, Iss. 8, pp. 1544-1556
Open Access | Times Cited: 18
TYK2 signaling promotes the development of autoreactive CD8+ cytotoxic T lymphocytes and type 1 diabetes
Keiichiro Mine, Seiho Nagafuchi, Satoru Akazawa, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
The beta cell-immune cell interface in type 1 diabetes (T1D)
Eddie A. James, Alok V. Joglekar, Amelia K. Linnemann, et al.
Molecular Metabolism (2023) Vol. 78, pp. 101809-101809
Open Access | Times Cited: 13
JAK inhibitors: a new choice for diabetes mellitus?
Mengjun Zhou, Qi Shen, Bo Li
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access
Allo Beta Cell transplantation: specific features, unanswered questions, and immunological challenge
Rossana Caldara, Valentina Tomajer, Paolo Monti, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Multi-omics characterization of type 2 diabetes associated genetic variation.
Ravi Mandla, Kimberly Lorenz, Xianyong Yin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Unravelling the Complex Interplay of Age, Comorbidities, and Multimorbidities in COVID-19 Disease Progression: Clinical Implications and Future Perspectives
Maria Shoukat, Haseeb Khan, Wajid Munir, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35570-e35570
Open Access | Times Cited: 3
The role of the interferon/JAK-STAT axis in driving islet HLA-I hyperexpression in type 1 diabetes
Mark A. Russell, Sarah J. Richardson, Noel G. Morgan
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 8
Screening and Prevention of Type 1 Diabetes: Where Are We?
Kimber M. Simmons, Emily K. Sims
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 12, pp. 3067-3079
Closed Access | Times Cited: 7
LncRNA ARGI Contributes to Virus‐Induced Pancreatic β Cell Inflammation Through Transcriptional Activation of IFN‐Stimulated Genes
Itziar González‐Moro, Koldo García‐Etxebarria, Luis Manuel Mendoza, et al.
Advanced Science (2023) Vol. 10, Iss. 25
Open Access | Times Cited: 7
Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in mice
Farooq Syed, Olivia Ballew, Chih‐Chun Lee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Recent progress in modeling and treating diabetes using stem cell-derived islets
Marlie M. Maestas, Maggie H Bui, Jeffrey R. Millman
Stem Cells Translational Medicine (2024) Vol. 13, Iss. 10, pp. 949-958
Open Access | Times Cited: 2
Tryptophan metabolism promotes immune evasion in human pancreatic β cells
Latif Rachdi, Zhicheng Zhou, Claire Berthault, et al.
EBioMedicine (2023) Vol. 95, pp. 104740-104740
Open Access | Times Cited: 6
Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human EndoC-βH1 β-cells against proinflammatory insults
Reinaldo S. Dos Santos, Daniel Guzman-Llorens, Atenea A. Perez-Serna, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Islet cells in human type 1 diabetes: from recent advances to novel therapies – a symposium-based roadmap for future research
James Cantley, Décio L. Eizirik, Esther Latres, et al.
Journal of Endocrinology (2023) Vol. 259, Iss. 1
Open Access | Times Cited: 5
Identification of common genes and pathways between type 2 diabetes and COVID-19
Ya Wang, Kai Li, Shuangyang Mo, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 1
Regulation of STAT1 signalling in human pancreatic β-cells by the lysine deacetylase, HDAC6; a new therapeutic opportunity in type 1 diabetes?
Kaiyven Afi Leslie, Christiana Lekka, Sarah J. Richardson, et al.
Diabetes (2024) Vol. 73, Iss. 9, pp. 1473-1485
Open Access | Times Cited: 1
Untangling the genetics of beta cell dysfunction and death in type 1 diabetes
Catherine C. Robertson, Ruth M. Elgamal, Belle A. Henry-Kanarek, et al.
Molecular Metabolism (2024) Vol. 86, pp. 101973-101973
Open Access | Times Cited: 1
Therapeutic Strategies Targeting Pancreatic Islet β-Cell Proliferation, Regeneration, and Replacement
Roy A Goode, Julia M. Hum, Michael A. Kalwat
Endocrinology (2022) Vol. 164, Iss. 1
Open Access | Times Cited: 6
Computational Characterization of Undifferentially Expressed Genes with Altered Transcription Regulation in Lung Cancer
Ruihao Xin, Qian Cheng, Xiaohang Chi, et al.
Genes (2023) Vol. 14, Iss. 12, pp. 2169-2169
Open Access | Times Cited: 2
Ameliorating and refining islet organoids to illuminate treatment and pathogenesis of diabetes mellitus
Yushan Li, Meiqi Xu, Jiali Chen, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top